A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
<p>Abstract</p> <p>Background</p> <p>The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is debated. We assessed the safety and activity of a lower dose of bevacizumab in pr...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2012-06-01
|
| Serie: | Journal of Ovarian Research |
| Accesso online: | http://www.ovarianresearch.com/content/5/1/17 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|